For pharmaceutical manufacturers, distributors, 3PLs, and compounding pharmacies, the final months of the year can bring a familiar compliance challenge: state license renewals. As December...
Insights
How Secure Is Your Licensing Service Provider?
State licensing compliance involves more than keeping track of expiration dates. It also involves protecting the sensitive information behind every license application and renewal....
National Pharmaceutical Licensing vs. State-by-State Licensing: What Companies Need to Know
For years, pharmaceutical companies operating across the United States have faced a familiar compliance challenge: there is no single license that allows a company to conduct every regulated...
The Risk of AI in Pharmaceutical Compliance: Why Regulatory Judgment Should Stay Human
Artificial intelligence is quickly becoming one of the most talked-about technologies in the pharmaceutical industry. AI is being promoted as a way to analyze enormous amounts of information,...
The Licensing Risks Hiding in Your Next Acquisition
In a pharmaceutical transaction, due diligence typically focuses on revenue, contracts, intellectual property, customers, employees, facilities, inventory, and financial liabilities. But there is...
The Rise of Compounding Pharmacies: Why Growth Is Bringing New State Licensing Challenges
For years, compounding pharmacies operated in a specialized corner of the pharmaceutical industry by serving patients whose medical needs could not be met by commercially available medications....
Alabama Raises the Stakes: Higher Penalties Signal a Tougher Era for Pharmaceutical Compliance
For pharmaceutical companies, a regulatory violation has always carried consequences. But in Alabama the potential financial consequences of discipline are about to become much more significant. The...
Regulatory Changes Do Not Stop at Your State Lines: Why Pharmaceutical Companies Must Continuously Monitor Compliance Changes Across Their Supply Chain
The regulatory landscape for pharmaceutical and medical device companies is not static. State boards of pharmacy, departments of health, controlled substance authorities, and other regulatory...
Puerto Rico’s GLP-1 Registration Landscape: Why FDA Approval Matters for Peptide Products
The demand for GLP-1 medications has transformed the pharmaceutical marketplace. Manufacturers, distributors, compounding pharmacies, telehealth organizations, and other healthcare businesses...
Why Proactive State Licensing Is Becoming a Competitive Advantage for CMOs and CDMOs
For years, many contract manufacturing organizations (CMOs) and contract drug manufacturing organizations (CDMOs) viewed state pharmaceutical licensing as a reactive process. If they were not...